Volume | 9,910,788 |
|
|||||
News | - | ||||||
Day High | 0.0013 | Low High |
|||||
Day Low | 0.0009 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
IFAN Financial Inc (PK) | IFAN | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0013 | 0.0009 | 0.0013 | 0.0013 | 0.0014 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
74 | 9,910,788 | $ 0.001176 | $ 11,658 | - | 0.000001 - 0.0024 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:26:08 | 15,000 | $ 0.0013 | USD |
IFAN Financial Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 1.58M | 1.21B | 684.14M | $ - | $ - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
2.26M | $ - | - | - | - |
IFAN Financial (PK) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IFAN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0007 | 0.0015 | 0.0005 | 0.0010098 | 31,090,437 | 0.0006 | 85.71% |
1 Month | 0.0002 | 0.0015 | 0.000001 | 0.0008842 | 12,140,509 | 0.0011 | 550.0% |
3 Months | 0.0001 | 0.0015 | 0.000001 | 0.0007534 | 6,203,093 | 0.0012 | 1,200.0% |
6 Months | 0.00075 | 0.0015 | 0.000001 | 0.000527 | 6,653,005 | 0.00055 | 73.33% |
1 Year | 0.00135 | 0.0024 | 0.000001 | 0.000749 | 4,460,069 | -0.00005 | -3.7% |
3 Years | 0.0004 | 0.052 | 0.000001 | 0.0120212 | 9,899,223 | 0.0009 | 225.0% |
5 Years | 0.0004 | 0.052 | 0.000001 | 0.0109383 | 6,814,221 | 0.0009 | 225.0% |
IFAN Financial (PK) Description
IFAN - Palantir Bioceuticals is a biopharmaceutical company offering holistic solutions to mental health illnesses. Palantir Bioceuticals use a radical innovation called psychedelic-assisted psychotherapy (PAP), supervised use of ketamine, MDMA, psilocybin, LSD, and ibogaine as part of elaborated psychotherapy programs. |